Advertisement

Ads Placeholder
Loading...

Klotho Neurosciences, Inc.

KLTO•NASDAQ
Healthcare
Biotechnology
$0.38
$-0.03(-7.10%)
U.S. Market opens in 1h 13m

Klotho Neurosciences, Inc. (KLTO) Stock Overview

Explore Klotho Neurosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap20.1M
P/E Ratio-2.01
EPS (TTM)$-0.30
ROE-2.02%
Fundamental Analysis

AI Price Forecasts

1 Month$0.44
3 Months$0.35
1 Year Target$0.24

KLTO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Klotho Neurosciences, Inc. (KLTO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.01 and a market capitalization of 20.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
29.50%
1-Month Change
-28.33%
3-Month Change
19.25%
6-Month Change
-18.31%
Year-to-Date (YTD) Change
19.25%
1-Year Change
66.38%
3-Year Change
-63.01%
5-Year Change
-63.01%
All-Time (Max) Change
-63.01%

Contact Information

https://klothoneuro.com
833 931 6330
13576 Walnut Street, Omaha, NE, 68144

Company Facts

30 Employees
IPO DateApr 29, 2022
CountryUS

Frequently Asked Questions